A neuroprotective role for the DNA damage checkpoint in tauopathy

Aging Cell

Volumn 11, Issue 2, 2012, Pages 360-362

  Khurana, Vikram ^a   Merlo, Paola ^a   Duboff, Brian ^a   Fulga, Tudor A ^a   Sharp, Katherine A ^a   Campbell, Shelagh D ^b   Götz, Jürgen ^c   Feany, Mel B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Alzheimer's disease; DNA damage; Drosophila

Indexed keywords

ATM PROTEIN; PROTEIN P53;

ALZHEIMER DISEASE; CELL CYCLE; DNA DAMAGE; DNA DAMAGE CHECKPOINT; GENETIC DATABASE; MITOSIS; NEUROPROTECTION; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; TAUOPATHY;

AGING; ANIMALS; CELL CYCLE CHECKPOINTS; DNA DAMAGE; MICE; TAUOPATHIES;

ANIMALIA;

EID: 84858340484     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2011.00778.x     Document Type: Note

References (14)

1. Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J. Neurosci. 25, 5446-5454.
2. Barlow C, Dennery PA, Shigenaga MK, Smith MA, Morrow JD, Roberts LJ 2nd, Wynshaw-Boris A, Levine RL (1999) Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl Acad. Sci. U S A 96, 9915-9919.
3. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870.
4. Culmsee C, Mattson MP (2005) p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun. 331, 761-777.
5. Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB (2007) Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J. Clin. Invest. 117, 236-245.
6. Herrup K, Yang Y (2007) Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat. Rev. Neurosci. 8, 368-378.
7. Ittner LM, Fath T, Ke YD, Bi M, van Eersel J, Li KM, Gunning P, Götz J (2008) Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc. Natl Acad. Sci. U S A 105, 15997-16002.
8. Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB (2006) TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr. Biol. 16, 230-241.
9. Kim D, Frank CL, Dobbin MM, Tsunemoto RK, Tu W, Peng PL, Guan JS, Lee BH, Moy LY, Giusti P, Broodie N, Mazitschek R, Delalle I, Haggarty SJ, Neve RL, Lu Y, Tsai LH (2008) Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60, 803-817.
10. Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y, Taniguchi T (1997) Changes of p53 in the brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 232, 418-421.
11. Kruman II, Wersto RP, Cardozo-Pelaez F, Smilenov L, Chan SL, Chrest FJ, Emokpae R Jr, Gorospe M, Mattson MP (2004) Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41, 549-561.
12. Lee Y, McKinnon PJ (2000) ATM dependent apoptosis in the nervous system. Apoptosis 5, 523-529.
13. Myung NH, Zhu X, Kruman II, Castellani RJ, Petersen RB, Siedlak SL, Perry G, Smith MA, Lee HG (2008) Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age (Dordr) 30, 209-215.
14. Wilson C, Henry S, Smith MA, Bowser R (2004) The p53 homologue p73 accumulates in the nucleus and localizes to neurites and neurofibrillary tangles in Alzheimer disease brain. Neuropathol. Appl. Neurobiol. 30, 19-29.